Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Targeted protein degradation is changing how drug discovery teams think about disease biology. For many years, small molecule programs were built around inhibition. | Explore how targeted protein degradation is reshaping drug discovery, enabling new approaches for difficult targets and advancing novel therapeutic modalities.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Astellas treatment offers new hope to a devastated rare disease community

Biotech M&A is accelerating. Track the deals that are happening here.

BeOne wins FDA approval in lymphoma race

FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended

FDA to reconsider treatment for rare cancer after its surprise rejection

The biotech news you need to read today

FDA revisits a rare cancer treatment it rejected a few months ago

Drug meant to make gene therapy safer may also make it less effective

Novo Nordisk's less-bad news on its Wegovy pill boosts earnings and share price